Grove Collaborative Holdings, Inc.
GROV NYSE Retail-Catalog & Mail-Order Houses Financials FY2020βFY2025
What Grove Collaborative Holdings, Inc. does
No business description yet.
- Legal name
- Grove Collaborative Holdings, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 5, 2026
- Accession Β· CIK
- 0001841761-26-000010
0001841761
Revenue and margins
Grove Collaborative Holdings, Inc. had $174M of revenue in fiscal 2025, down 14.6% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$8.1M in fiscal 2025, β4.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Grove Collaborative Holdings, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 5.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Grove Collaborative Holdings, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $78.4M | $81.1M | $86.4M | $19.6M | $8.5M |
| Debt incl. finance leases | $66.9M | $61.2M | $71.7M | $7.5M | $7.5M |
| Net debt / EBITDA | β8.1x | β | β | β | β |
| Debt / equity | β | 2.3x | 8.8x | β | β |
| Interest coverage | β0.7x | β14.6x | β2.2x | β1.8x | β9.2x |
| Current ratio | 2.0x | 2.5x | 3.5x | 1.7x | 1.3x |
| Quick ratio | 1.2x | 1.7x | 2.7x | 0.9x | 0.6x |
| Total assets | $182M | $174M | $151M | $65.0M | $53.1M |
| Total liabilities | $151M | $148M | $133M | $48.8M | $45.3M |
| Shareholders' equity | β$456M | $26.5M | $8.1M | β$8.5M | β$17.0M |
| Net debt (β = net cash) | β$11.4M | β$19.9M | β$14.7M | β$12.1M | β$1.0M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 2 / 9 | 4 / 9 | 4 / 9 | 3 / 9 |
| Accruals ratio | β | 2.5% | 4.8% | β21.7% | β16.4% | β8.1% |
| Altman Z'' | β | β9.49 | β12.89 | β11.06 | β33.23 | β41.50 |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $364M | $384M | $322M | $259M | $203M | $174M |
| Gross profit | $176M | $189M | $155M | $137M | $109M | $93.3M |
| Research and development | $18.7M | $23.4M | $22.5M | $16.4M | $18.5M | $7.5M |
| Operating income | β$66.5M | β$3.6M | β$141M | β$35.3M | β$22.5M | β$11.3M |
| Interest expense | $5.6M | $5.2M | $9.7M | $16.1M | $12.8M | $1.2M |
| Pretax income | β$72.2M | β$136M | β$87.7M | β$43.2M | β$27.4M | β$11.7M |
| Income tax | $0.0M | $0.1M | $0.1M | $0.0M | $0.0M | $0.0M |
| Net income | β$72.3M | $2.7M | β$87.7M | β$43.2M | β$27.4M | β$11.7M |
| Net income to common | β | β$136M | β$87.7M | β$44.4M | β$28.3M | β$13.2M |
| Diluted EPS | β$13.45 | β$79.28 | β$4.85 | β$1.28 | β$0.76 | β$0.34 |
| Diluted shares | 0.01B | 0.00B | 0.02B | 0.03B | 0.04B | 0.04B |
| Cash flow | ||||||
| Cash from operations | β$83.7M | β$1.9M | β$96.3M | β$8.0M | β$9.7M | β$7.0M |
| Capital expenditure | $4.8M | $5.8M | $4.2M | $3.0M | $1.8M | $1.2M |
| Free cash flow | β$88.5M | β$7.7M | β$100M | β$11.0M | β$11.5M | β$8.1M |
| Depreciation and amortization | $4.1M | $5.0M | $5.7M | $5.8M | $9.8M | $1.7M |
| Stock-based compensation | $7.8M | $14.6M | $45.7M | $15.5M | $12.0M | $4.3M |
| Share buybacks | $0.0M | $0.3M | $0.0M | β | β | β |
| Dividends and buybacks | $0.0M | $0.3M | $0.0M | β | β | β |
| Balance sheet | ||||||
| Cash and short-term investments | $177M | $78.4M | $81.1M | $86.4M | $19.6M | $8.5M |
| Total debt | β | $66.9M | $61.2M | $71.7M | $7.5M | $7.5M |
| Current assets | β | $141M | $142M | $124M | $44.9M | $34.7M |
| Current liabilities | β | $69.2M | $57.5M | $35.0M | $27.1M | $27.7M |
| Inventory | β | $54.5M | $44.1M | $28.8M | $19.4M | $18.4M |
| Property and equipment, net | β | $15.9M | $14.5M | $11.6M | $3.7M | $3.7M |
| Intangible assets | β | β | β | β | $0.7M | $2.3M |
| Total assets | β | $182M | $174M | $151M | $65.0M | $53.1M |
| Total liabilities | β | $151M | $148M | $133M | $48.8M | $45.3M |
| Preferred stock | β | $0.0M | β | β | β | β |
| Shareholders' equity | β$340M | β$456M | $26.5M | $8.1M | β$8.5M | β$17.0M |
| Margins | ||||||
| Gross margin | 48.3% | 49.1% | 48.1% | 53.0% | 53.8% | 53.7% |
| Operating margin | β18.3% | β0.9% | β43.8% | β13.6% | β11.1% | β6.5% |
| EBITDA margin | β17.1% | 0.4% | β42.1% | β11.4% | β6.3% | β5.5% |
| Net margin | β19.8% | 0.7% | β27.3% | β16.7% | β13.5% | β6.7% |
| FCF margin | β24.3% | β2.0% | β31.3% | β4.2% | β5.7% | β4.7% |
| Returns | ||||||
| Return on capital | β | β | β1,676.3% | β | β | β |
| Return on capital employed | β | β3.2% | β120.9% | β30.5% | β59.4% | β44.6% |
| Return on equity | β | β | β | β249.5% | β | β |
| Return on assets | β | 1.5% | β49.2% | β26.6% | β25.4% | β19.8% |
| Return on tangible equity | β | β | β330.6% | β546.9% | β | β |
| Growth | ||||||
| Revenue growth | β | 5.3% | β16.2% | β19.4% | β21.5% | β14.6% |
| Net income growth | β | β | β3,350.6% | β | β | β |
| Share count change | β | β68.1% | 956.0% | 92.2% | 6.4% | 5.4% |
| Financial health | ||||||
| Net debt / EBITDA | β | β8.1x | β | β | β | β |
| Debt / equity | β | β | 2.3x | 8.8x | β | β |
| Interest coverage | β11.9x | β0.7x | β14.6x | β2.2x | β1.8x | β9.2x |
| Current ratio | β | 2.0x | 2.5x | 3.5x | 1.7x | 1.3x |
| Quick ratio | β | 1.2x | 1.7x | 2.7x | 0.9x | 0.6x |
| Capital allocation | ||||||
| Capex / revenue | 1.3% | 1.5% | 1.3% | 1.2% | 0.9% | 0.7% |
| Stock comp / revenue | 2.1% | 3.8% | 14.2% | 6.0% | 5.9% | 2.5% |
| Quality scores | ||||||
| Piotroski F-score | β | β | 2.0 | 4.0 | 4.0 | 3.0 |
| Altman Z'' | β | β9.5 | β12.9 | β11.1 | β33.2 | β41.5 |
| Accruals ratio | β | 2.5% | 4.8% | β21.7% | β16.4% | β8.1% |
Source: SEC EDGAR XBRL filings (CIK 0001841761). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.